Elwan Alaa

12PUBLICATIONS
34CO-AUTHORS
Biomolecular modelling and designCheminformatics and quantitative structure-activity relationshipsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 27, 2025
Design, synthesis, and cytotoxic evaluation of quinazoline-based derivatives as VEGER-2 inhibitors: comparative study against EGFR kinase activity, induction of apoptosis, and molecular docking study.

Reda R Mabrouk, Arafa Musa, Maged Mohammed Saleh Al Ward

|Apr 24, 2025
Targeting VEGFR-2 in breast cancer: synthesis and <i>in silico</i> and <i>in vitro</i> characterization of quinoxaline-based inhibitors.

Ibrahim H Eissa, Alaa Elwan, Mustafa A Al-Qadhi

|Nov 14, 2024
Design and synthesis of new nicotinamides as immunomodulatory VEGFR-2 inhibitors and apoptosis inducers.

Reda G Yousef, Ibrahim H Eissa, Hazem Elkady

|Dec 15, 2023
New nicotinamide derivatives as potential anticancer agents targeting VEGFR-2: design, synthesis, <i>in vitro</i>, and <i>in silico</i> studies.

Reda G Yousef, Ibrahim H Eissa, Hazem Elkady

|Sep 21, 2023
Synthesis, biological evaluation and computer-aided discovery of new thiazolidine-2,4-dione derivatives as potential antitumor VEGFR-2 inhibitors.

Hazem Elkady, Osama A El-Dardir, Alaa Elwan

|Jul 19, 2023
New theobromine derivatives inhibiting VEGFR-2: design, synthesis, antiproliferative, docking and molecular dynamics simulations.

Hazem A Mahdy, Hazem Elkady, Mohammed S Taghour

Pageof 2

Frequent Collaborators

9 joint publications

Ibrahim H Eissa

8 joint publications

Hazem Elkady

5 joint publications

Eslam B Elkaeed

5 joint publications

Ahmed M Metwaly